|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL. | A61K 38/16 | (2006.01) |
| (11) | Number of the document | 2586456 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12155003.2 |
| Date of filing the European patent application | 2005-10-31 | |
| (97) | Date of publication of the European application | 2013-05-01 |
| (45) | Date of publication and mention of the grant of the patent | 2016-01-20 |
| (46) | Date of publication of the claims translation | 2016-06-10 |
| (30) | Number | Date | Country code |
| 623342 P | 2004-10-29 | US |
| (72) |
Defrees, Shawn, US
|
| (73) |
89 Bio Ltd.,
6 Hamada Street, Herzliya, Israel 4673340,
IL
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Fibroblastų augimo faktoriaus (FGF) pertvarkymas ir glikopegiliacija |
| Remodeling and glycopegylation of fibroblast growth factor (FGF) |
| Payment date | Validity (years) | Amount | |
| 2024-09-24 | 347.00 EUR |